Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA; Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA; Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
Am J Hum Genet. 2013 Jun 6;92(6):1001-7. doi: 10.1016/j.ajhg.2013.04.024. Epub 2013 May 23.
Infantile myofibromatosis (IM) is a disorder of mesenchymal proliferation characterized by the development of nonmetastasizing tumors in the skin, muscle, bone, and viscera. Occurrence within families across multiple generations is suggestive of an autosomal-dominant (AD) inheritance pattern, but autosomal-recessive (AR) modes of inheritance have also been proposed. We performed whole-exome sequencing (WES) in members of nine unrelated families clinically diagnosed with AD IM to identify the genetic origin of the disorder. In eight of the families, we identified one of two disease-causing mutations, c.1978C>A (p.Pro660Thr) and c.1681C>T (p.Arg561Cys), in PDGFRB. Intriguingly, one family did not have either of these PDGFRB mutations but all affected individuals had a c.4556T>C (p.Leu1519Pro) mutation in NOTCH3. Our studies suggest that mutations in PDGFRB are a cause of IM and highlight NOTCH3 as a candidate gene. Further studies of the crosstalk between PDGFRB and NOTCH pathways may offer new opportunities to identify mutations in other genes that result in IM and is a necessary first step toward understanding the mechanisms of both tumor growth and regression and its targeted treatment.
婴儿纤维瘤病(IM)是一种间充质增殖紊乱,其特征是在皮肤、肌肉、骨骼和内脏中发展出非转移性肿瘤。在多个世代的家族中发生提示常染色体显性(AD)遗传模式,但也提出了常染色体隐性(AR)遗传模式。我们对 9 个具有 AD IM 临床诊断的无关家族成员进行了全外显子组测序(WES),以确定该疾病的遗传起源。在其中 8 个家族中,我们在 PDGFRB 中鉴定出两种致病突变之一,c.1978C>A(p.Pro660Thr)和 c.1681C>T(p.Arg561Cys)。有趣的是,一个家族既没有这两种 PDGFRB 突变,但所有受影响的个体在 NOTCH3 中都有 c.4556T>C(p.Leu1519Pro)突变。我们的研究表明,PDGFRB 突变是 IM 的一个原因,并突出了 NOTCH3 作为候选基因。进一步研究 PDGFRB 和 NOTCH 途径之间的相互作用可能为鉴定导致 IM 的其他基因突变提供新的机会,这是理解肿瘤生长和消退及其靶向治疗机制的必要第一步。